title: [Ventricular premature contraction observed after anti-cancer chemotherapy with ifosfamide].
abstract: We encountered 3 cases of ventricule premature contraction (VPC) after anti-cancer chemotherapy with ifosfamide (IFM). These cases were administered IFM of more than 2 g/body/day for 3 days, and they were more than 70 years old. They had no cardiovascular disorder before the chemotherapy. Among them, 1 case who received a total dose of 15.0 g of IFM showed severe VPC. She had also received a total dose of 155 mg of doxorubicin (ADM) in earlier treatment. There was also 1 case, whose VPC was aggravated after anti-cancer chemotherapy with IFM. He had dilated cardiomyopathy and had already showed frequent VPC before the chemotherapy. His VPC became more frequent after the chemotherapy. IFM was a common agent among the anti-cancer agents used in these cases. We must be careful for the occurrence of VPC when more than 2 g/body/day of IFM is administered to patients more than 70 years old. An increase in the total dose of IFM or former ADM may cause severe VPC. When IFM is given a patient with VPC, the existing VPC may be aggravated.
authors.affiliation: Dept. of Nuclear Medicine and Radiology, Tohoku University.
authors.forename: J
authors.initials: J
authors.lastname: Takahashi
authors.forename: R
authors.initials: R
authors.lastname: Kawashima
authors.forename: Y
authors.initials: Y
authors.lastname: Abe
authors.forename: H
authors.initials: H
authors.lastname: Fukuda
authors.forename: K
authors.initials: K
authors.lastname: Kubota
authors.forename: K
authors.initials: K
authors.lastname: Yamada
authors.forename: T
authors.initials: T
authors.lastname: Sato
mesh_terms: D000368:Aged; D005117:Cardiac Complexes, Premature / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy
chemical_list: D007069:Ifosfamide